Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.
|Articles|October 25, 2010
Neptune Enters Pharmaceutical Market
Neptune Technology and Bioressources Inc. (Neptune; Laval, QC), a supplier of krill oil for dietary supplements, has introduced Onemia, a medical food for the pharmaceutical market.
Advertisement
Onemia is a marine-based omega-3 phospholipid deemed by FDA as safe and effective for managing chronic cardiometabolic disorders. Available through prescription, the product can be used alone or in combination with other cardiovascular drugs.
"The success of Onemia will provide short-term revenues which will contribute to Acasti's further research and development projects while establishing a validation of Acasti's omega-3 phospholipid pipeline…paving the road for CaPre, our prescription drug candidate in development," said Tina Sampalis, MD, PhD, president of Neptune.
Onemia is manufactured by Neptune and sold through the company’s subsidiary, Acasti Pharma Inc.
Advertisement
Related to this article
The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.
Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.
Session speakers at SupplySide Global 2026 covered consumer survey data, extraction methods, dosing, and claims for formulators working with functional mushrooms in beverages and foods.
Panelists at SupplySide Global 2026 discussed protein's limits, shifting supplement formats, clean-label expectations, and plainer ingredient communication.
Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Mit Metah, executive vice president at Unibar, about the launch of ElaQuin and how it connects to Bellaneo, Unibar’s melanin-inhibiting cosmeceutical ingredient.
At SupplySide Global 2026, Jordi Riera of Kaneka Probiotics describes the company’s focus on research and probiotics for women’s health.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
What the Interim Compounding Pathway for Peptides Could Mean for Supplement Brands
2
Formulating With Functional Mushrooms: What Extraction and Dose Mean for Beverages and Foods
3
Vitaquest's 2027 Consumer Trends Forecast
4
SupplySide Global Panel Weighs Purpose, Transparency, and Affordability in Nutrition
5